Pharmacological abnormalities in atopic dermatitis

Jon M. Hanifin

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Numerous investigations have described cutaneous and systemic physiological and pharmacological aberrations in atopic dermatitis and the atopic diathesis. Some of these studies set the stage for a focus upon cyclic nucleotide abnormalities. Elevated leukocyte cyclic AMP‐phosphodiesterase accounts for low intracellular cyclic AMP levels in atopic dermatitis. The resultant permissive effect correlates with abnormal functional parameters such as increased basophil histamine release and in vitro IgE synthesis. In vitro and clinical use of phosphodiesterase inhibitors corrects abnormal parameters and may indicate future therapeutic directions.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
StatePublished - Jan 1989
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Pharmacological abnormalities in atopic dermatitis'. Together they form a unique fingerprint.

Cite this